Coronary Artery Disease
References
Citations
Williams CL, et al. (2002). Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 106(1): 143–160.
McSweeney JC, et al. (2003). Women's early warning symptoms of acute myocardial infarction. Circulation, 108(21): 2619–2623.
American Heart Association (2006). Heart disease and stroke statistics—2006 update. Circulation, 113(6): e85–e151.
Grundy SM (2001). United States cholesterol guidelines 2001: Expanded scope of intensive low-density lipoprotein-lowering therapy. American Journal of Cardiology, 88(7B): 23J–27J.
U.S. Preventive Services Task Force (2008). Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 148(11): 846–854.
Koenig W (2001). Inflammation and coronary artery disease: An overview. Cardiology in Review, 9(1): 31–35.
Snow V, et al. (2004). Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 141(7): 562–567. Also available online: http://www.annals.org/cgi/reprint/141/7/562.pdf.
Goldenberg I, et al. (2003). Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Archives of Internal Medicine, 163(19): 2301–2305.
Silagy C, et al. (2006). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.
Jolliffe JA, et al. (2006). Exercise-based rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.
Foster C, et al. (2004). Cardiovascular disorders: Primary prevention. Clinical Evidence (12): 159–192.
Smith SC Jr, et al. (2006). ACC/AHA/SCAI 2005 guidelines update for percutaneous coronary intervention: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation, 113(1): 156–175.
Gami A (2006). Secondary prevention of ischaemic cardiac events, search date July 2004. Online version of Clinical Evidence (15): 1–31.
Morice M (2002). A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New England Journal of Medicine, 346(23): 1773–1780.
Other Works Consulted
BARI 2D Study Group (2009). A randomized trial of therapies for Type 2 diabetes and coronary artery disease. New England Journal of Medicine, 360(24): 2503–2515.
Hirsch J, et al. (2008). Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest, 133(6): 71–109.
U.S. Preventive Services Task Force (2008). Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 148(11): 846–854.
U.S. Preventive Services Task Force (2009). Aspirin for the Prevention of Cardiovascular Disease. Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://www.ahrq.gov/clinic/uspstf/uspsasmi.htm.
 Go to previous section |  Go to top of page |  Go to next section |
| Author: | Robin Parks, MS | Last Updated: May 29, 2008 |
| Medical Review: |
Caroline S. Rhoads, MD - Internal Medicine
Robert A. Kloner, MD, PhD - Cardiology Ruth Schneider, MPH, RD - Diet and Nutrition |
|
 | ||
